Akums Drugs and Pharmaceutical (AKUMS) — Free Cash Flow Generation Index
Akums Drugs and Pharmaceutical (AKUMS) has a Free Cash Flow Generation Index of 0.41x as of March 2025. Free cash flow of Rs1.93 Billion represents 0% of operating cash flow (Rs4.65 Billion). Read debt load of Akums Drugs and Pharmaceutical for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Akums Drugs and Pharmaceutical Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for Akums Drugs and Pharmaceutical across 4 annual periods. Explore AKUMS capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year Free Cash Flow Generation Index for Akums Drugs and Pharmaceutical. For the full company profile including market capitalisation, see Akums Drugs and Pharmaceutical market cap and net worth.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | Rs1.93 Billion | Rs4.65 Billion | Rs2.72 Billion | ▲ +10.6% |
| 2024 | 0.38x | Rs1.87 Billion | Rs4.98 Billion | Rs3.11 Billion | ▲ +143.5% |
| 2023 | -0.86x | Rs-1.52 Billion | Rs1.77 Billion | Rs3.29 Billion | ▲ +87.8% |
| 2022 | -7.09x | Rs-2.26 Billion | Rs318.54 Million | Rs2.58 Billion | — |